Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MCHP stock price vs ASML: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ASML's multiple
Needs ASML P/E.
Implied fair value · at MCHP's multiple
Needs MCHP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
USD conversion input: 1 EUR = 1.126700 USD. FX date unavailable.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MICROCHIP TECHNOLOGY INCORPORATED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ASML HOLDING NV · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTEL CORP
MCHP vs INTC
TEXAS INSTRUMENTS INC
MCHP vs TXN
ADVANCED MICRO DEVICES INC
MCHP vs AMD
QUALCOMM INC/DE
MCHP vs QCOM
APPLIED MATERIALS INC /DE
MCHP vs AMAT
SKYWORKS SOLUTIONS, INC.
MCHP vs SWKS
LAM RESEARCH CORP
MCHP vs LRCX
KLA CORP
MCHP vs KLAC
TERADYNE, INC
MCHP vs TER
ENTEGRIS INC
MCHP vs ENTG
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MCHP can materially reaccelerate margins and growth toward ASML-like levels, then holding or buying may make sense because the current valuation already embeds a very large discount to the P/E-based implied value; otherwise, the data favors reducing exposure because MCHP remains expensive relative to its own DCF range and materially weaker than ASML on profitability and capital efficiency.
MCHP’s current price of $74.29 implies a large downside versus the provided P/E-derived value of $12.63, indicating a severe valuation disconnect on earnings. Even though MCHP trades at a lower P/S and EV/Revenue than ASML, the absolute valuation still looks stretched given its weaker growth and profitability profile.
Supporting Metrics
